QUADRANT CAPITAL GROUP LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$5,448
-48.5%
142
-21.1%
0.00%
-100.0%
Q1 2024$10,581
+1.6%
180
+3.4%
0.00%0.0%
Q4 2023$10,416
+32.3%
174
-15.9%
0.00%0.0%
Q3 2023$7,875
-29.7%
207
+68.3%
0.00%0.0%
Q2 2023$11,206
+38.1%
1230.0%0.00%0.0%
Q1 2023$8,114
+102.8%
123
+46.4%
0.00%0.0%
Q2 2022$4,00084
+950.0%
0.00%
Q3 2021$080.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders